New heart valve design aims to outperform current standards
Disease control
Not yet recruiting
This study is testing a new artificial heart valve called DurAVR against currently approved valves for people with severe aortic stenosis, a dangerous narrowing of the heart's main valve. About 1,650 participants will be randomly assigned to receive either the new valve or an exi…
Phase: NA • Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC